A client is prescribed with carbamazepine (Tegretol) for the treatment of bipolar disorder. Which of the following laboratory results indicates that the client is experiencing a side effect of this medication?

Questions 92

ATI RN

ATI RN Test Bank

ATI Pharmacology Test Bank Questions

Question 1 of 5

A client is prescribed with carbamazepine (Tegretol) for the treatment of bipolar disorder. Which of the following laboratory results indicates that the client is experiencing a side effect of this medication?

Correct Answer: A

Rationale: Carbamazepine can cause leukopenia, including neutropenia, as a side effect. A neutrophil count of 1,200/mm3 is below the normal range and indicates a potential adverse effect. Platelet count, uric acid, and SGPT levels are within normal ranges and do not indicate side effects. Therefore, the neutrophil count is the concerning result.

Question 2 of 5

Regarding drugs used in the treatment of status epilepsy:

Correct Answer: D

Rationale: Phenytoin controls status epilepticus via anticonvulsant action, not sedation, so that's false. It precipitates in dextrose, only saline-compatible, making that false. Diazepam's effect is short-lived, not long-lasting, so that's incorrect. Phenobarbitone commonly causes respiratory depression, a true statement, due to CNS suppression. Phenytoin's rate is 50 mg/min max. This side effect limits phenobarbitone's use, requiring ventilatory support in status management.

Question 3 of 5

The nurse is teaching a class for clients about over-the-counter (OTC) medications. The nurse determines that education has been effective when the clients make which statement?

Correct Answer: C

Rationale: Reading OTC labels and seeking clarification from a doctor if unclear ensures safe use, reflecting effective education on responsibility. Always calling the doctor is overly cautious-OTC drugs are for self-management. Pharmacists help, but label-reading is primary. Assuming OTC safety ignores risks like ibuprofen's bleeding potential. Label focus empowers clients, balancing autonomy with safety, a key learning outcome.

Question 4 of 5

Mark the location of the beginning of the plateau phase on this dose-response relationship curve.

Correct Answer: D

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 5 of 5

The nurse has completed medication education with the patient who is receiving lithium (Eskalith). What is the priority patient outcome?

Correct Answer: B

Rationale: Lithium toxicity (e.g., tremors, confusion) at narrow therapeutic range (0.6-1.2) is life-threatening-knowing signs (e.g., nausea) and prevention (e.g., hydration) is priority, per safety. Work, ADLs, and mood stability follow but aren't immediate risks. Toxicity awareness saves lives, per education.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions